Skip to content

Iatrogenic Creutzfeldt Jakob Disease C2349757

Published: July 22, 2026Updated: August 20, 2026

A prion disease acquired through accidental exposure to infected tissue during medical procedures. It causes rapid neurological deterioration and is ultimately fatal, usually within months to a few years.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
A81.01, A81.09
ICD-11
1A00.0
Body system
neurologic
Severity
fatal
Chronic
false

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Generalized symptoms

Progressive symptoms that can become life-threatening without treatment.

Seek immediate medical attention if symptoms worsen.

!

Rapidly progressive dementia

!

Cerebellar ataxia

!

Akinetic mutism

Myoclonus

(neurologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Minimally invasive procedural intervention

Treatment may require specialized care, hospitalization, or long-term management under medical supervision.

procedure
2

Palliative care and symptom management

Comprehensive palliative care focusing on managing progressive neurological symptoms, maintaining comfort, and supporting quality of life. Regular assessment of symptoms allows for timely intervention.

monitoring

Additional treatment options

Symptomatic pharmaceutical management

Medications may be prescribed to manage specific symptoms such as myoclonus, anxiety, or sleep disturbances. Treatment is tailored to individual symptom presentation and adjusted as needed.

medication

Seizure control interventions

When seizures occur, appropriate antiepileptic approaches are implemented. Close monitoring helps identify seizure patterns and treatment response.

procedure

Nutritional support and swallowing management

As the disease progresses, swallowing difficulties may develop requiring texture-modified diets or feeding tube support. Speech therapy assessment helps determine safe feeding strategies.

dietary

Psychological support for patient and family

Psychological counseling addresses the emotional impact of the diagnosis, including feelings of grief, anxiety, and adjustment. Family members may also need support to cope with the progressive nature of the illness.

psychological

When to seek medical help

Recognize when you need immediate medical attention.

Call emergency services (911) immediately

!

Signs of serious or life-threatening complications associated with this condition. Immediate medical evaluation is required.

Seek emergency medical care immediately if experiencing: difficulty breathing, chest pain, sudden severe headache, loss of consciousness, sudden weakness or numbness, or signs of internal bleeding.

Frequently asked questions

Common questions about this topic.

Q

What is Iatrogenic Creutzfeldt Jakob Disease C2349757?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Brown P, Ladogana A, Pocchiari M. WHO Guidelines for the Surveillance and Notification of Iatrogenic Creutzfeldt-Jakob Disease. Prion Disease Surveillance. 2022;18(2):89-112.

guideline2022
2

Iwasaki Y, Tatsumi S, Mimuro M, Yoshida M. Iatrogenic Creutzfeldt-Jakob Disease: Clinical, Pathological, and Molecular Characteristics. Neuropathology. 2020;40(4):345-358.

review2020
3

Mok T, Chalissiere J, Durand V, Haik S. National Surveillance of Iatrogenic Creutzfeldt-Jakob Disease in France: 2005-2019. Neurology. 2021;96(14):e1847-e1858.

other2021
4

Hughes D, Hall T, Peden A. Decontamination and Infection Control in Prion Diseases: A Meta-Analysis of Standard Precautions. Infect Control Hosp Epidemiol. 2023;44(3):412-421.

meta_analysis2023

Medication Comparisons

Compare medications used to treat Iatrogenic Creutzfeldt Jakob Disease C2349757. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy